INDUCTION THERAPY IN RENAL TRANSPLANTATION WITH ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB- A SINGLE CENTRE RETROSPECTIVE STUDY
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 52
Abstract
BACKGROUND Renal transplantation is the best available form of renal replacement therapy. Induction therapy pre-transplant reduces the incidence of graft rejections. We present a retrospective study comparing different induction methods in living donor kidney transplantation in our institute. MATERIALS AND METHODS We analysed 423 live kidney transplant recipients of our center from Dec 2010 to Nov 2015, 344 of whom received basiliximab as induction and 79 r-ATG as induction. Primary outcomes like patient survival and graft survival, secondary outcomes like graft rejections, infections, PTDM, recurrence of disease were compared. RESULTS 5yr patient survival rates were observed to be 91% and 88% respectively whereas graft survival rates were 93% and 86% respectively for ATG and basiliximab. Incidence of rejections was similar (p=0.867). Cellular rejections were more common with basiliximab (7.9% vs. 3.8%) but statistically not significant (P=0.498). Infections in the post-operative period were more common in r-ATG arm especially LRTI (P=0.011) and diarrhoeal episodes (P=0.005). Incidence of cytopenias was more in rATG arm during hospital stay (10.1 vs. 2.6% P=0.002) and also the later followup period (25 vs. 12.4% P<0.001). Incidence of PTDM was more in basiliximab (33.8% vs. 22.8%) arm but not significant (P=0.061). CONCLUSION ATG and basiliximab are non-inferior to one another as induction therapy. ATG is effective in high immunological risk groups with equivalent graft and patient survival with increased risk of Lower respiratory tract infections and diarrhoea in immediate post-transplant periods and increased risk for cytopenias compared to basiliximab. Basiliximab has slightly increased risk of post-transplant diabetes mellitus. Careful selection of the agent in an individual based on risk rather than a question of efficacy of agents is the key to successful transplantation.
Authors and Affiliations
Hareesh M. V. K, Sharma R. K.
Keywords
Related Articles
- EP ID EP608444
- DOI 10.18410/jebmh/2018/723
- Views 74
- Downloads 0
TUBAL LIGATION, REPRODUCTIVE EXPERIENCES AND RISK OF OVARIAN CANCER- A PROSPECTIVE STUDY
BACKGROUND Ovarian cancer is the most lethal malignancy of the female reproductive system. Risk of ovarian cancer increases with age, but the rate of increase slows after the menopause. Tubal ligation confers long-term p...
AN OPHTHALMOLOGICAL STUDY OF ECTOPIA LENTIS, WITH MULTIFARIOUS AETIOPATHOGENESIS, DIVERSE CLINICAL PRESENTATIONS AND VARIED PROGNOSES
BACKGROUND Ectopia lentis is a hereditary or acquired displacement or malposition of the lens, from its normal position, with traumatic and non-traumatic aetiopathogenesis like homocystinuria due to cystathionine ß-synth...
A COMPARATIVE STUDY OF hsCRP AND LDL-C/HDL-C RATIO IN ACUTE CORONARY SYNDROME
BACKGROUND Cardiovascular diseases (CVD) have been the leading cause of morbidity and mortality in India. Recent trends indicate that the disease is being seen in younger age groups also. It has a significant presence in...
PREDICTORS OF CORONARY SLOW FLOW OR NO REFLOW PHENOMENA AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION
BACKGROUND The treatment of acute myocardial infarction (AMI) is thought to restore antegrade blood flow in the infarct-related artery with percutaneous coronary interventions (PCI). The present study was undertaken to i...
A STUDY OF FASTING INSULIN LEVELS IN NON-OBESE INDIVIDUALS WITH ESSENTIAL HYPERTENSION AND ITS COMPLICATIONS
BACKGROUND An association between essential hypertension and defective insulin secretion has been identified. To study the fasting insulin levels in non-obese, non-diabetic Hypertensive subjects. Although hyperinsulinemi...